SCHEMBL977943

SCHEMBL977943

Cc1nc(C(F)(F)F)c(C(=O)Nc2ccccc2-c2cc(F)c(F)c(F)c2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
HTT P42858 2/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
WDR5 P61964 1/20 0.42
NTRK1 P04629 2/20 0.42
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CHRM3 P20309 1/20 0.40
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12920787 0.91 MAPT (0.46) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL14564516 0.90 MAPT (0.47) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL344007 0.88 MAPT (0.43) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL9225609 0.88 MAPT (0.54) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL14564508 0.87 MAPT (0.47) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL13210783 0.87 NTRK1 (0.51) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL975700 0.87 KMT2A (0.55) MAPTHTTSMN1; SMN2GAAMEN1
SCHEMBL14564507 0.87 CHRM3 (0.47) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL27713456 0.86 MAPT (0.47) MAPTHTTKDM4ESMN1; SMN2TDP1
SCHEMBL978883 0.86 MAPT (0.47) MAPTHTTKDM4ESMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888545-B1 THIAZOLE CARBOXYLIC ACID ANILIDES BASF SE (DE) 2010-08-25 EP claimed
US-20090099019-A1 Thiazolecarboxanilides BASF AKTIENGESELLSCHAFT (DE) 2009-04-16 US claimed
US-20110004021-A1 THIAZOLECARBOXANILIDES DIETZ JOCHEN 2011-01-06 US disclosed
US-20090099019-A1 Thiazolecarboxanilides BASF AKTIENGESELLSCHAFT (DE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004021-A1 THIAZOLECARBOXANILIDES CBR3, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MAPT 3011/4885HTT 2031/4885KDM4E 2187/4885
US-20090099019-A1 Thiazolecarboxanilides CBR3, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MAPT 3011/4885HTT 2031/4885KDM4E 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.